22 | Temozolomide (Temodar)FDA LinkGeneric
03/2024
-
03/2009 |
16 | Proteins (Proteins, Gene)FDA Link
12/2023
-
04/2006 |
13 | Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
01/2024
-
12/2011 |
10 | Messenger RNA (mRNA)IBA
11/2022
-
04/2006 |
8 | MethyltransferasesIBA
01/2024
-
04/2014 |
8 | Bevacizumab (Avastin)FDA Link
11/2022
-
10/2014 |
7 | DNA (Deoxyribonucleic Acid)IBA
01/2024
-
04/2014 |
7 | Biomarkers (Surrogate Marker)IBA
01/2024
-
08/2011 |
7 | AntigensIBA
11/2023
-
01/2012 |
7 | CytokinesIBA
01/2023
-
04/2014 |
7 | LigandsIBA
12/2019
-
11/2009 |
6 | Chimeric Antigen ReceptorsIBA
11/2023
-
01/2018 |
6 | InterferonsIBA
01/2022
-
09/2012 |
6 | Transforming Growth Factors (Transforming Growth Factor)IBA
01/2022
-
02/2013 |
5 | SteroidsIBA
01/2024
-
12/2010 |
5 | Alkylating AgentsIBA
12/2023
-
04/2014 |
5 | MicroRNAs (MicroRNA)IBA
12/2016
-
08/2011 |
5 | IntegrinsIBA
07/2016
-
02/2013 |
4 | O-(6)-methylguanineIBA
01/2024
-
04/2014 |
4 | Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2023
-
11/2009 |
4 | Immune Checkpoint InhibitorsIBA
01/2022
-
06/2017 |
3 | Proteasome Endopeptidase Complex (Proteasome)IBA
03/2024
-
11/2009 |
3 | NivolumabIBA
01/2023
-
01/2017 |
3 | Lomustine (CCNU)FDA Link
01/2023
-
12/2013 |
3 | Peptides (Polypeptides)IBA
12/2022
-
02/2013 |
3 | EpitopesIBA
10/2020
-
01/2018 |
3 | CilengitideIBA
03/2016
-
02/2013 |
3 | Anticonvulsants (Antiepileptic Drugs)IBA
03/2016
-
04/2014 |
3 | CaspasesIBA
04/2014
-
11/2009 |
2 | 14- methyl- 20- oxa- 5,7,14,26- tetraazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8(27),9,11,16,21,23- decaeneIBA
04/2024
-
12/2023 |
2 | SteamIBA
04/2024
-
12/2023 |
2 | marizomibIBA
03/2024
-
10/2020 |
2 | Interferon Type IIBA
02/2023
-
01/2020 |
2 | Rituximab (Mabthera)FDA Link
01/2023
-
01/2014 |
2 | VaccinesIBA
12/2022
-
06/2017 |
2 | vinyltriethoxysilane (VTES)IBA
01/2022
-
01/2020 |
2 | B7-H1 AntigenIBA
01/2022
-
10/2017 |
2 | Phosphotransferases (Kinase)IBA
01/2022
-
11/2019 |
2 | Telomerase (Telomerase Reverse Transcriptase)IBA
01/2021
-
11/2015 |
2 | Antisense OligonucleotidesIBA
12/2019
-
01/2017 |
2 | ErbB Receptors (EGF Receptor)IBA
11/2019
-
10/2014 |
2 | Liposomes (Liposome)IBA
10/2019
-
01/2018 |
2 | Small Interfering RNA (siRNA)IBA
10/2017
-
08/2010 |
2 | Methotrexate (Mexate)FDA LinkGeneric
09/2017
-
07/2015 |
2 | Protein Isoforms (Isoforms)IBA
01/2017
-
11/2013 |
2 | Levetiracetam (Keppra)FDA LinkGeneric
03/2016
-
04/2014 |
2 | Growth Differentiation Factor 15IBA
02/2016
-
08/2010 |
2 | ImmunosorbentsIBA
01/2016
-
08/2010 |
2 | EnzymesIBA
01/2016
-
08/2010 |
2 | Angiogenesis InhibitorsIBA
11/2015
-
02/2013 |
2 | Monoclonal AntibodiesIBA
07/2015
-
11/2013 |
2 | Adrenal Cortex Hormones (Corticosteroids)IBA
03/2015
-
12/2010 |
2 | Fas Ligand Protein (Fas Ligand)IBA
02/2011
-
11/2009 |
1 | Gabapentin (Neurontin)FDA LinkGeneric
01/2024 |
1 | Neurotransmitter Agents (Neurotransmitter)IBA
01/2024 |
1 | Sulfasalazine (Azulfidine)FDA LinkGeneric
01/2024 |
1 | Glutamic Acid (Glutamate)FDA Link
01/2024 |
1 | Memantine (Namenda)FDA Link
01/2024 |
1 | Cyclin-Dependent Kinases (cdk Proteins)IBA
12/2023 |
1 | Anti-Bacterial Agents (Antibiotics)IBA
09/2023 |
1 | Anti-Infective Agents (Microbicides)IBA
09/2023 |
1 | ManganeseIBA
09/2023 |
1 | PlatinumIBA
01/2023 |
1 | Neoplasm Antigens (Tumor Antigens)IBA
01/2023 |
1 | lisavanbulinIBA
01/2023 |
1 | tepotinibIBA
01/2023 |
1 | Metalloproteases (Metalloproteinases)IBA
01/2023 |
1 | Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
01/2023 |
1 | tisagenlecleucelIBA
01/2023 |